366 related articles for article (PubMed ID: 28430981)
1. Central Nervous System GLP-1 Receptors Regulate Islet Hormone Secretion and Glucose Homeostasis in Male Rats.
Jessen L; Smith EP; Ulrich-Lai Y; Herman JP; Seeley RJ; Sandoval D; D'Alessio D
Endocrinology; 2017 Jul; 158(7):2124-2133. PubMed ID: 28430981
[TBL] [Abstract][Full Text] [Related]
2. Acute but not chronic activation of brain glucagon-like peptide-1 receptors enhances glucose-stimulated insulin secretion in mice.
Tudurí E; Beiroa D; Porteiro B; López M; Diéguez C; Nogueiras R
Diabetes Obes Metab; 2015 Aug; 17(8):789-99. PubMed ID: 25962313
[TBL] [Abstract][Full Text] [Related]
3. A physiological role of glucagon-like peptide-1 receptors in the central nervous system of Suncus murinus (house musk shrew).
Chan SW; Lin G; Yew DT; Rudd JA
Eur J Pharmacol; 2011 Oct; 668(1-2):340-6. PubMed ID: 21756894
[TBL] [Abstract][Full Text] [Related]
4. Acute activation of central GLP-1 receptors enhances hepatic insulin action and insulin secretion in high-fat-fed, insulin resistant mice.
Burmeister MA; Ferre T; Ayala JE; King EM; Holt RM; Ayala JE
Am J Physiol Endocrinol Metab; 2012 Feb; 302(3):E334-43. PubMed ID: 22094469
[TBL] [Abstract][Full Text] [Related]
5. Intra-islet glucagon confers β-cell glucose competence for first-phase insulin secretion and favors GLP-1R stimulation by exogenous glucagon.
Cabrera O; Ficorilli J; Shaw J; Echeverri F; Schwede F; Chepurny OG; Leech CA; Holz GG
J Biol Chem; 2022 Feb; 298(2):101484. PubMed ID: 34896391
[TBL] [Abstract][Full Text] [Related]
6. Regulation of islet hormone release and gastric emptying by endogenous glucagon-like peptide 1 after glucose ingestion.
Salehi M; Vahl TP; D'Alessio DA
J Clin Endocrinol Metab; 2008 Dec; 93(12):4909-16. PubMed ID: 18827000
[TBL] [Abstract][Full Text] [Related]
7. Endogenous hindbrain glucagon-like peptide-1 receptor activation contributes to the control of food intake by mediating gastric satiation signaling.
Hayes MR; Bradley L; Grill HJ
Endocrinology; 2009 Jun; 150(6):2654-9. PubMed ID: 19264875
[TBL] [Abstract][Full Text] [Related]
8. Elimination of glucagon-like peptide 1R signaling does not modify weight gain and islet adaptation in mice with combined disruption of leptin and GLP-1 action.
Scrocchi LA; Hill ME; Saleh J; Perkins B; Drucker DJ
Diabetes; 2000 Sep; 49(9):1552-60. PubMed ID: 10969840
[TBL] [Abstract][Full Text] [Related]
9. Pancreatic GLP-1 receptor activation is sufficient for incretin control of glucose metabolism in mice.
Lamont BJ; Li Y; Kwan E; Brown TJ; Gaisano H; Drucker DJ
J Clin Invest; 2012 Jan; 122(1):388-402. PubMed ID: 22182839
[TBL] [Abstract][Full Text] [Related]
10. Arcuate glucagon-like peptide 1 receptors regulate glucose homeostasis but not food intake.
Sandoval DA; Bagnol D; Woods SC; D'Alessio DA; Seeley RJ
Diabetes; 2008 Aug; 57(8):2046-54. PubMed ID: 18487451
[TBL] [Abstract][Full Text] [Related]
11. Glucagon-like peptide-1 and islet lipolysis.
Sörhede Winzell M; Ahrén B
Horm Metab Res; 2004; 36(11-12):795-803. PubMed ID: 15655711
[TBL] [Abstract][Full Text] [Related]
12. Hyperphagia and increased fat accumulation in two models of chronic CNS glucagon-like peptide-1 loss of function.
Barrera JG; Jones KR; Herman JP; D'Alessio DA; Woods SC; Seeley RJ
J Neurosci; 2011 Mar; 31(10):3904-13. PubMed ID: 21389245
[TBL] [Abstract][Full Text] [Related]
13. Peripheral, but not central, GLP-1 receptor signaling is required for improvement in glucose tolerance after Roux-en-Y gastric bypass in mice.
Carmody JS; Muñoz R; Yin H; Kaplan LM
Am J Physiol Endocrinol Metab; 2016 May; 310(10):E855-61. PubMed ID: 27026085
[TBL] [Abstract][Full Text] [Related]
14. Chronic exposure to GLP-1R agonists promotes homologous GLP-1 receptor desensitization in vitro but does not attenuate GLP-1R-dependent glucose homeostasis in vivo.
Baggio LL; Kim JG; Drucker DJ
Diabetes; 2004 Dec; 53 Suppl 3():S205-14. PubMed ID: 15561912
[TBL] [Abstract][Full Text] [Related]
15. Novel role of GLP-1 receptor signaling in energy expenditure during chronic high fat diet feeding in rats.
Krieger JP; Langhans W; Lee SJ
Physiol Behav; 2018 Aug; 192():194-199. PubMed ID: 29654813
[TBL] [Abstract][Full Text] [Related]
16. Is GLP-1 a hormone: Whether and When?
D'Alessio D
J Diabetes Investig; 2016 Apr; 7 Suppl 1(Suppl 1):50-5. PubMed ID: 27186356
[TBL] [Abstract][Full Text] [Related]
17. The common hepatic branch of the vagus is not required to mediate the glycemic and food intake suppressive effects of glucagon-like-peptide-1.
Hayes MR; Kanoski SE; De Jonghe BC; Leichner TM; Alhadeff AL; Fortin SM; Arnold M; Langhans W; Grill HJ
Am J Physiol Regul Integr Comp Physiol; 2011 Nov; 301(5):R1479-85. PubMed ID: 21849636
[TBL] [Abstract][Full Text] [Related]
18. Potentiation of insulin secretion and improvement of glucose intolerance by combining a novel G protein-coupled receptor 40 agonist DS-1558 with glucagon-like peptide-1 receptor agonists.
Nakashima R; Yano T; Ogawa J; Tanaka N; Toda N; Yoshida M; Takano R; Inoue M; Honda T; Kume S; Matsumoto K
Eur J Pharmacol; 2014 Aug; 737():194-201. PubMed ID: 24858371
[TBL] [Abstract][Full Text] [Related]
19. Endogenous glucagon-like peptide 1 controls endocrine pancreatic secretion and antro-pyloro-duodenal motility in humans.
Schirra J; Nicolaus M; Roggel R; Katschinski M; Storr M; Woerle HJ; Göke B
Gut; 2006 Feb; 55(2):243-51. PubMed ID: 15985560
[TBL] [Abstract][Full Text] [Related]
20. Activation of Glucagon-Like Peptide-1 Receptor Promotes Neuroprotection in Experimental Autoimmune Encephalomyelitis by Reducing Neuroinflammatory Responses.
Lee CH; Jeon SJ; Cho KS; Moon E; Sapkota A; Jun HS; Ryu JH; Choi JW
Mol Neurobiol; 2018 Apr; 55(4):3007-3020. PubMed ID: 28456941
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]